Department of Urology, University of Rennes, Rennes, France.
Department of Cardiology, University of Rennes, Rennes, France.
Am Surg. 2023 Nov;89(11):4772-4779. doi: 10.1177/00031348221135774. Epub 2022 Oct 27.
Surgery is the treatment of choice for pheochromocytoma. However, this surgery carries a risk of hemodynamic instability (HDI). The aim of this study was to report complications associated with this procedure, to identify risk factors for HDI during surgery, and its impact on postoperative outcomes.
The charts of all patients who underwent adrenalectomy for pheochromocytoma in two academic centers between 2006 and 2020 were retrospectively reviewed. The primary outcome was HDI defined by a systolic blood pressure >160 mmHg or a mean blood pressure <60 mmHg intraoperatively. The secondary outcomes of interest were the total duration of HDI, the occurrence of intraoperative arrhythmia, perioperative cardiovascular events, and postoperative complications.
205 patients were included. HDI occurred intraoperatively in 155 patients (75.6%) but only 6 (3.2%) experienced arrhythmia. Thirty-eight postoperative complications were reported (18.6%) but only nine were ≥3 according to Clavien-Dindo (4.4%). There were 10 postoperative cardiovascular events (5.7%). Patients with intraoperative HDI had higher rates of postoperative complications (21.3% vs 10%; = .07), major postoperative complications (5.8% vs 0%; = .12) and cardiovascular events (6.5% vs 0%; = .12). Factors associated with intraoperative HDI in univariate analysis were age (OR = 8.14; = .006), high blood pressure preoperatively (OR = 2.16; = .04), tumor size (OR = 15.83; = .0001), and urinary normetanephrine level (OR = 9.33; = .04).
In multidisciplinary centers, the overall morbidity of adrenalectomy for pheochromocytoma is low. HDI during adrenalectomy for pheochromocytoma is highly prevalent but rarely associated with major cardiovascular events. There might be a link between HDI and postoperative cardiovascular events.
手术是治疗嗜铬细胞瘤的首选方法。然而,这种手术存在血流动力学不稳定(HDI)的风险。本研究旨在报告与该手术相关的并发症,确定手术期间发生 HDI 的危险因素及其对术后结果的影响。
回顾性分析了 2006 年至 2020 年期间在两个学术中心接受肾上腺切除术治疗嗜铬细胞瘤的所有患者的病历。主要结局是术中收缩压>160mmHg 或平均血压<60mmHg 的 HDI。次要结局包括 HDI 的总持续时间、术中心律失常的发生、围手术期心血管事件和术后并发症。
共纳入 205 例患者。155 例(75.6%)患者术中发生 HDI,但仅 6 例(3.2%)发生心律失常。报告了 38 例术后并发症(18.6%),但仅 9 例根据 Clavien-Dindo 分类为≥3 级(4.4%)。有 10 例术后心血管事件(5.7%)。术中发生 HDI 的患者术后并发症发生率较高(21.3%比 10%; =.07),主要术后并发症(5.8%比 0%; =.12)和心血管事件(6.5%比 0%; =.12)。单因素分析中与术中 HDI 相关的因素为年龄(OR=8.14; =.006)、术前高血压(OR=2.16; =.04)、肿瘤大小(OR=15.83; =.0001)和尿中去甲变肾上腺素水平(OR=9.33; =.04)。
在多学科中心,嗜铬细胞瘤肾上腺切除术的总体发病率较低。嗜铬细胞瘤切除术期间发生的 HDI 非常普遍,但很少与重大心血管事件相关。HDI 与术后心血管事件之间可能存在关联。